Cytological diagnosis | Number of cases | Percentage | Histological diagnosis | Frequency | Percentage | Incidence of malignancy | |
---|---|---|---|---|---|---|---|
Bethesda 2 | 45 | 73.77% | Benign | Nodular hyperplasia | 6 | 13.3% | 11.1% |
Multinodular hyperplasia | 30 | 66.7% | |||||
Adenomatous hyperplasia | 2 | 4.4% | |||||
Hashimoto thyroiditis | 1 | 2.2% | |||||
Folicular adenoma | 1 | 2.2% | |||||
Malignant | Follicular variant of papillary carcinoma | 1 | 2.2% | ||||
Papillary carcinoma | 3 | 6.7% | |||||
Medullary carcinoma | 1 | 2.2% | |||||
Bethesda 3 | 6 | 9.84% | Benign | Multinodular hyperplasia | 3 | 50% | 33.3% |
Adenomatous hyperplasia | 1 | 16.7% | |||||
Malignant | Follicular variant of papillary carcinoma | 1 | 16.7% | ||||
Follicular carcinoma | 1 | 16.7% | |||||
Bethesda 4 | 4 | 6.56% | Benign | Adenomatous hyperplasia | 1 | 25% | 25% |
Hashimoto thyroiditis | 1 | 25% | |||||
Hurthle cell adenoma | 1 | 25% | |||||
Malignant | Papillary carcinoma | 1 | 25% | ||||
Bethesda 5 | 4 | 6.56% | Malignant | Papillary carcinoma | 3 | 75% | |
Non hodgkin lymphoma | 1 | 25% | |||||
100% | |||||||
3.28% | Malignant | Papillary carcinoma | 2 | 100% | |||
Bethesda 6 | 2 | 100% | |||||
Total | 61 | 100.00% | 61 |